Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcome

Thomas Prebet, Anne-Catherine Lhoumeau, Christine Arnoulet, Anaïs Aulas, Sylvie Marchetto, Stéphane Audebert, Francesca Puppo, Christian Chabannon, Danielle Sainty, Marie-Josée Santoni, Michael Sebbagh, Virginia Summerour, Yannick Huon, Won-Sik Shin, Seung-Taek Lee, Benjamin Esterni, Norbert Vey, Jean-Paul Borg

Blood (2010) 116 (13): 2315–2323.

https://doi.org/10.1182/blood-2010-01-262352

Published: 2010

Includes: Supplemental data

Journal Articles

Expression of the Cell Polarity Protein PTK7 in Acute Myeloid Leukaemia.

Thomas Prebet, MD, Anne Catherine Lhoumeau, PharmD, Christine Arnoulet, PharmD, Sylvie Marchetto, Christian Chabannon, MD, PhD, Danielle Sainty, MD, Norbert Vey, MD, Jean Paul Borg, PharmD, PhD

Blood (2008) 112 (11): 1478.

https://doi.org/10.1182/blood.V112.11.1478.1478

Published: 2008

Journal Articles

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients with Refractory or Relapsed Non-Hodgkin’s Lymphoma (NHL).

Hugues de Lavallade, MD, Reda Bouabdallah, MD, Catherine Faucher, MD, Sabine Furst, MD, Jean El-Cheikh, MD, Norbert Vey, MD, Anne-Marie Stoppa, MD, Danielle Sainty, MD, Christine Arnoulet, Luc Xerri, MD, Philippe Cassier, MD, Jean-Albert Gastaut, MD, Didier Blaise, MD, Mohamad Mohty, MD, PhD

Blood (2006) 108 (11): 5356.

https://doi.org/10.1182/blood.V108.11.5356.5356

Published: 2006

Journal Articles

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) as Salvage Treatment for Relapsing Multiple Myeloma (MM): A “Donor” vs. “No Donor” Comparison.

Hugues de Lavallade, MD, Patrick Ladaique, MD, Catherine Faucher, MD, Sabine Furst, MD, Jean El-Cheikh, MD, Anne-Marie Stoppa, MD, Diane Coso, MD, Reda Bouabdallah, MD, Norbert Vey, MD, Danielle Sainty, MD, Christian Chabannon, MD, PhD, Jean-Albert Gastaut, MD, Didier Blaise, MD, Mohamad Mohty, MD, PhD

Blood (2006) 108 (11): 3003.

https://doi.org/10.1182/blood.V108.11.3003.3003

Published: 2006

Journal Articles

Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCR dull phenotype induction

Cyril Fauriat, Sylvaine Just-Landi, Françoise Mallet, Christine Arnoulet, Danielle Sainty, Daniel Olive, Regis T. Costello

Blood (2006) 109 (1): 323–330.

https://doi.org/10.1182/blood-2005-08-027979

Published: 2006

Journal Articles

Feasability of High Dose Melphalan and Peripheral Blood Stem Cell Support(IPC-LAM 2000) for Patients over 60 Years with Acute Myeloid Leukemia(AML) in First Remission(CR1):Final Analysis.

Anne-Marie Stoppa, MD, Norbert Vey, MD, Reda Bouabdallah, MD, Catherine Faucher, MD, Diane Coso, MD, Aude Charbonnier, MD, PhD, Jean Marc Schianno, MD, Therese Aurran, MD, Christian Chabannon, MD, PhD, Danielle Sainty, MD, Marina Lafage, MD, PhD, Didier Blaise, MD, Jean Albert Gastaud, MD, Dominique Maraninchi, MD

Blood (2005) 106 (11): 2922.

https://doi.org/10.1182/blood.V106.11.2922.2922

Published: 2005

Journal Articles

Impact of Recovery of CD4 and CD8 Lymphocyte Subsets on Acute GVHD after Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT).

Mohamad Mohty, Beatrice Gaugler, Catherine Faucher, Danielle Sainty, Christine Arnoulet, Jean-Albert Gastaut, Patrice Viens, Daniel Olive, Didier Blaise

Blood (2005) 106 (11): 1425.

https://doi.org/10.1182/blood.V106.11.1425.1425

Published: 2005

Journal Articles

FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in mice

Géraldine Guasch, Bénédicte Delaval, Christine Arnoulet, Min-Jue Xie, Luc Xerri, Danielle Sainty, Daniel Birnbaum, Marie-Josèphe Pébusque

Blood (2004) 103 (1): 309–312.

https://doi.org/10.1182/blood-2003-05-1690

Published: 2004

Journal Articles

Clinical and biologic features of CD4 + CD56 + malignancies

Blood (2002) 99 (5): 1556–1563.

https://doi.org/10.1182/blood.V99.5.1556

Published: 2002

Journal Articles

Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment

Mohamad Mohty, David Jarrossay, Marina Lafage-Pochitaloff, Christine Zandotti, Francine Brière, Xavier-Nicolas de Lamballeri, Daniel Isnardon, Danielle Sainty, Daniel Olive, Béatrice Gaugler

Blood (2001) 98 (13): 3750–3756.

https://doi.org/10.1182/blood.V98.13.3750

Published: 2001

Journal Articles

Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party

Blood (2000) 96 (4): 1297–1308.

https://doi.org/10.1182/blood.V96.4.1297

Published: 2000

Journal Articles

A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements

Danielle Sainty, Vincenzo Liso, Angelo Cantù-Rajnoldi, David Head, Marie-Joëlle Mozziconacci, Christine Arnoulet, Laurence Benattar, Susanna Fenu, Marco Mancini, Eliane Duchayne, François-Xavier Mahon, Norma Gutierrez, Françoise Birg, Andrea Biondi, David Grimwade, Marina Lafage-Pochitaloff, Anne Hagemeijer, Georges Flandrin

Blood (2000) 96 (4): 1287–1296.

https://doi.org/10.1182/blood.V96.4.1287

Published: 2000

NARROW

The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcome

Expression of the Cell Polarity Protein PTK7 in Acute Myeloid Leukaemia.

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for Patients with Refractory or Relapsed Non-Hodgkin’s Lymphoma (NHL).

Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) as Salvage Treatment for Relapsing Multiple Myeloma (MM): A “Donor” vs. “No Donor” Comparison.

Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCR dull phenotype induction

Feasability of High Dose Melphalan and Peripheral Blood Stem Cell Support(IPC-LAM 2000) for Patients over 60 Years with Acute Myeloid Leukemia(AML) in First Remission(CR1):Final Analysis.

Impact of Recovery of CD4 and CD8 Lymphocyte Subsets on Acute GVHD after Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT).

FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation, induces a fatal myeloproliferative disease in mice

Clinical and biologic features of CD4 + CD56 + malignancies

Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment

Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party

A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only